You are here: Home / News / FDA panel rejects Eisai’s leukemia drug

FDA panel rejects Eisai’s leukemia drug

February 9, 2012 By

Related posts:

  1. FDA panel rejects Novartis drug for gout
  2. U.S. panel rejects Lilly dye for brain plaque
  3. Leukemia drug pulled from U.S. sparks new interest
  4. FDA panel gives nod to Affymax drug for anemia
  5. FDA panel gives nod to Affymax drug for anemia

Filed Under: News Tagged With: ,